Filter
2131
Text search:
КОВИД-19
Featured
236
4
Language
Document type
625
306
287
244
123
114
113
111
71
53
30
28
22
3
1
Countries / Regions
238
197
183
144
133
124
103
97
91
86
85
81
79
75
73
67
67
48
47
46
44
42
42
39
37
32
30
29
29
28
27
26
25
24
23
23
22
22
22
21
21
20
20
18
17
17
16
16
16
15
14
14
13
12
12
12
12
12
12
11
11
11
11
10
10
10
10
9
9
9
9
8
8
8
8
8
8
8
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
2123
41
27
16
16
14
8
Toolboxes
1920
40
24
9
8
8
5
4
3
3
2
2
2
2
1
1
1
1
1
Rev Méd Hondur, Vol 88, Núm 2, 202
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
Framework for Fair, Equitable and Timely Allocation of COVID-19 Vaccines in Africa. Highlights Day 1
The virtual conference, co-organised by the Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC) brought together African leaders, public health professionals and researchers, policymakers, business leaders and civil society and commun
...
Vertreter besorgniserregender Virusvarianten (variants of concern, kurz VOC) wurden weltweit aber auch in Europa, identifiziert. Molekularbiologische Details zu den Varianten sind unter SARS-CoV-2: Virologische Basisdaten und Virusvarianten abrufbar.
Die Bundesländer sind für die Organisation der Impfung gegen Corona zuständig. Sie betreiben die Impfzentren, vergeben Termine und planen den Einsatz der mobilen Teams in Pflegeheimen. Hier finden Sie die Infoseite Ihres Bundeslandes zur Corona-Schutzimpfung.
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppe sowie zu Wechselwirkungen und Nebenwirkungen.
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppen sowie zu Wechselwirkungen und Nebenwirkungen von Impfstoffen und Arzneimitteln zu COVID-19 und SARS-CoV-2
This website has been created to provide accurate and up-to-date information about Sputnik V.
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h
...
11/05/2020
Prevenir a contaminação de superfícies e manter condições adequadas de limpeza e desinfecção nos espaços públicos é fundamental para mitigar a transmissão do vírus e proteger a saúde dos trabalhadores e do público em geral. As superfícies com alta frequência de contato (m
...
Recomendações gerais: • Colocar o paciente em um quarto individual bem ventilado (com as janelas abertas). • Limitar o movimento do paciente pela casa e minimizar o espaço a ser compartilhado. Certificar-se de que os espaços compartilhados estejam bem ventilados. • Separar os espaços para
...
Navegue pelos dados do Sistema Único de Saúde - SUS, com informações estratégicas e conheça tudo sobre a COVID-19 de forma transparente e analítica
Nota INformatIva Nº 13/2020 - SE/GaB/SE/mS
September 2020
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
